Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Monitoring for COVID-19 by universal testing in a homeless shelter in Germany: a prospective feasibility cohort study.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- معلومة اضافية
- المصدر:
Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE
- بيانات النشر:
Original Publication: London : BioMed Central, [2001-
- الموضوع:
- نبذة مختصرة :
Background: Living conditions in homeless shelters facilitate the transmission of COVID-19. Social determinants and pre-existing health conditions place homeless people at increased risk of severe disease. Described outbreaks in homeless shelters resulted in high proportions of infected residents and staff members. In addition to other infection prevention strategies, regular shelter-wide (universal) testing for COVID-19 may be valuable, depending on the level of community transmission and when resources permit.
Methods: This was a prospective feasibility cohort study to evaluate universal testing for COVID-19 at a homeless shelter with 106 beds in Berlin, Germany. Co-researchers were recruited from the shelter staff. A PCR analysis of saliva or self-collected nasal/oral swab was performed weekly over a period of 3 weeks in July 2020. Acceptability and implementation barriers were analyzed by process evaluation using mixed methods including evaluation sheets, focus group discussion and a structured questionnaire.
Results: Ninety-three out of 124 (75%) residents were approached to participate in the study. Fifty-one out of the 93 residents (54.8%) gave written informed consent; thus 41.1% (51 out of 124) of all residents were included in the study. Among these, high retention rates (88.9-93.6%) of a weekly respiratory specimen were reached, but repeated collection attempts, as well as assistance were required. Around 48 person-hours were necessary for the sample collection including the preparation of materials. A self-collected nasal/oral swab was considered easier and more hygienic to collect than a saliva specimen. No resident was tested positive by RT-PCR. Language barriers were the main reason for non-participation. Flexibility of sample collection schedules, the use of video and audio materials, and concise written information were the main recommendations of the co-researchers for future implementation.
Conclusions: Voluntary universal testing for COVID-19 is feasible in homeless shelters. Universal testing of high-risk facilities will require flexible approaches, considering the level of the community transmission, the available resources, and the local recommendations. Lack of human resources and laboratory capacity may be a major barrier for implementation of universal testing, requiring adapted approaches compared to standard individual testing. Assisted self-collection of specimens and barrier free communication may facilitate implementation in homeless shelters. Program planning must consider homeless people's needs and life situation, and guarantee confidentiality and autonomy.
(© 2021. The Author(s).)
- References:
Lancet Respir Med. 2020 Dec;8(12):1181-1191. (PMID: 32979308)
Lancet Public Health. 2020 Apr;5(4):e186-e187. (PMID: 32171054)
Lancet Infect Dis. 2020 Nov;20(11):1231-1232. (PMID: 32530425)
CMAJ Open. 2021 Jan 11;9(1):E1-E9. (PMID: 33436450)
Health Promot J Austr. 2021 Apr;32(2):359-360. (PMID: 32378768)
Lancet Microbe. 2020 Jul;1(3):e101-e102. (PMID: 32835337)
BMC Med Res Methodol. 2013 Sep 18;13:117. (PMID: 24047204)
Lancet Infect Dis. 2020 Nov;20(11):1233-1234. (PMID: 32679088)
JAMA Netw Open. 2020 Dec 1;3(12):e2028195. (PMID: 33351082)
Lancet. 2020 Mar 28;395(10229):1054-1062. (PMID: 32171076)
Lancet Public Health. 2021 Apr;6(4):e202-e209. (PMID: 33556328)
PLoS Med. 2021 Aug 12;18(8):e1003735. (PMID: 34383750)
MMWR Morb Mortal Wkly Rep. 2020 May 01;69(17):523-526. (PMID: 32352954)
Lancet Infect Dis. 2020 Nov;20(11):1232-1233. (PMID: 32679080)
JAMA Intern Med. 2013 Feb 11;173(3):189-95. (PMID: 23318302)
J Nerv Ment Dis. 2017 Mar;205(3):173-177. (PMID: 26785056)
Int J Infect Dis. 2021 Apr;105:1-6. (PMID: 33578010)
Med J Aust. 2020 May;212(8):384-384.e1. (PMID: 32266965)
N Engl J Med. 2020 Nov 26;383(22):e120. (PMID: 32997903)
MMWR Morb Mortal Wkly Rep. 2020 May 01;69(17):521-522. (PMID: 32352957)
JAMA. 2020 Jun 2;323(21):2191-2192. (PMID: 32338732)
Clin Infect Dis. 2021 Nov 2;73(9):e2978-e2984. (PMID: 32898272)
JAMA. 2020 Jun 9;323(22):2249-2251. (PMID: 32374370)
EClinicalMedicine. 2021 Aug;38:101032. (PMID: 34316550)
Lancet. 2014 Oct 25;384(9953):1529-40. (PMID: 25390578)
Sci Adv. 2021 Jan 1;7(1):. (PMID: 33219112)
Lancet Infect Dis. 2020 Nov;20(11):1234-1235. (PMID: 32679086)
Lancet. 2018 Jan 20;391(10117):241-250. (PMID: 29137869)
Lancet Infect Dis. 2020 Nov;20(11):1233. (PMID: 32679083)
- Contributed Indexing:
Keywords: COVID-19; Homeless shelter; Homelessness; Infection control; Monitoring; Pandemic; SARS-CoV-2
- الموضوع:
Date Created: 20211213 Date Completed: 20211214 Latest Revision: 20221207
- الموضوع:
20240829
- الرقم المعرف:
PMC8665323
- الرقم المعرف:
10.1186/s12879-021-06945-4
- الرقم المعرف:
34895157
No Comments.